Health authorities plan to introduce so-called "multi-cancer" blood tests at a number of general practitioner surgeries in the near future, officials have announced. The measure is intended to improve early detection of several abdominal cancers that are frequently diagnosed late.
These tests are built to screen for signs of multiple cancer types from a single blood sample. The programme will specifically aim to identify cancers of the liver, ovaries and pancreas — malignancies that can be difficult to spot early because their symptoms are often vague and non-specific.
Detecting these cancers at an earlier stage may allow patients to access treatment sooner and could improve outcomes. Current diagnostic pathways for abdominal cancers rely heavily on symptom recognition and imaging investigations, and delays in referral and diagnosis are a recognised challenge for clinicians and patients alike.
Officials say the rollout to some GP surgeries is the first step in wider evaluation of the tests in routine primary care. Positive results from the blood screen would be expected to prompt further diagnostic investigations. Authorities will need to balance potential benefits against practical considerations, including test performance, follow-up capacity, false positives or negatives, and how the approach fits with existing cancer services.
The move reflects growing interest in blood-based screening tools as a route to finding cancers earlier and more efficiently. Health services plan to monitor the impact of the initial rollout closely before deciding on any broader expansion.